The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Sign in to access this content
Sign InSeveral major financial institutions have revised their price targets upward for key NYSE-listed companies, reflecting optimism in their individual performance trajectories. Robert W. Baird increased its price target for Medtronic (MDT) to $93.00 while maintaining a neutral rating. In the tech and entertainment sector, KeyCorp raised Spotify's (SPOT) price target to $745.00 following robust quarterly earnings that surpassed both revenue and EPS estimates. Additionally, Mizuho boosted Corteva's (CTVA) price target to $94.00 with an outperform rating, supported by fiscal year 2026 guidance despite a recent revenue miss. These revisions indicate sustained analyst confidence and suggest potential upside for these specific equities following their latest fiscal updates. Overall, the adjustments signal a bullish sentiment localized to these specific market players.